artesunate-pyronaridine | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

326 results for “artesunate-pyronaridine”

Trials

View all 287 →

Not yet recruiting

A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate

12 participants · First posted Jul 3, 2023

Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate

56 participants · First posted Feb 1, 2012

PACTR202402599048090

Efficacy and safety of pyronaridine/artesunate and pyronaridine/artesunate/praziquantel for treatment of uncomplicated Schistosoma haematobium infection in Gabonese adolescents and childre

108 participants

Drugs

View all 27 →

Artesunate/Pyronaridine Phosphate

pyronaridine + artesunate

Investigational

Pyronaridine

Conditions: Acute Falciparum Malaria, Acute Malaria caused by plasmodium vivax

C₂₉H₃₂ClN₅O₂ · Rx

News

View all 12 →

Single-Dose Malaria Treatment Achieves 93% Cure Rate in Phase 3 Trial, Matching Standard Multi-Day Therapy

Antimalarial Drug Efficacy Remains High in Mozambique and Liberia Despite Regional Resistance Concerns

Promising Single-Dose Malaria Therapy SPAP Advances Toward Pan-African Clinical Trial

Page 1 of 33